Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-27

Clinical Trial Update: Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial update for grass pollen allergy showing results in rhinitis and rhinoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Inmunotek S.L. | Conditions: Rhinitis, Rhinoconjunctivitis | Phase 2 | Status: COMPLETED